Timing and indications for colectomy in chronic ulcerative colitis: Surgical consideration

Digestive Diseases

Volumn 28, Issue 3, 2010, Pages 501-507

  Cima, Robert R ^a  

^a Mayo Clinic   (United States)

Author keywords

Colectomy; Surgery; Total proctocolectomy; Ulcerative colitis, chronic

Indexed keywords

BLEEDING; COLON RESECTION; CONFERENCE PAPER; DISEASE SEVERITY; HUMAN; PERFORATION; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; TOXIC MEGACOLON; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ANASTOMOSIS, SURGICAL; CHRONIC DISEASE; COLECTOMY; COLITIS, ULCERATIVE; COLONIC POUCHES; HUMANS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957887624     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320409     Document Type: Conference Paper

References (38)

1. Truelove SC, Witts LJ: Cortisone in ulcer-ative colitis: preliminary report on therapeutic trial. Br Med J 1954; 2: 375-378.
2. Truelove SC, Witts LJ: Cortisone in ulcer-ative colitis: final report on a therapeutic trial. Br Med J 1955; 2:1041-1048.
3. Bullard KM, Madoff RD, Gemlo BT: Is ileo-anal pouch function stable with time? Results of a prospective audit. Dis Colon Rectum 2002; 45:299-304.
4. Farouk R, Pemberton JH, Wolff BG, et al: Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis. Ann Surg 2000; 231: 919-926.
5. Fazio VW, Ziv Y, Church JM, et al: Ileal pouch-anal anastomoses complications and function in 1,005 patients. Ann Surg 1995; 222: 120-127.
6. Martin A, Dinca M, Leone L, et al: Quality of life after proctocolectomy and ileo-anal anastomosis for severe ulcerative colitis. Am J Gastroenterol 1998; 93: 166-169.
7. Fazio VW, O'Riordan MG, Lavery IC, et al: Long-term functional outcome and quality of life after stapled restorative proctocolec-tomy. Ann Surg 1999; 230: 575-584.
8. Weinryb RM, Gustavsson JP, Liljeqvist L, et al: A prospective study of the quality of life after pelvic pouch operation. J Am Coll Surg 1995; 18 0 : 589-595.
9. Larson DW, Dozois EJ, Piotrowicz K, et al: Laparoscopic-assisted vs. open ileal pouch-anal anastomosis: functional outcome in a case-matched series. Dis Colon Rectum 2005; 48:1845-1850.
10. Larson DW, Cima RR, Dozois EJ, et al: Safety, feasibility, and short-term outcomes of laparoscopic ileal-pouch anal anastomosis a single institution case-matched experience. Ann Surg 2006; 243:667-672.
11. Kingham TP, Pachter, HL: Colonic anasto-motic leak: risk factors, diagnosis, and treatment. J Am Coll Surg 2009; 208:269-278.
12. Makela J T, K iviniemi H, Laitinen S: Risk factors for anastomosis leakage after left-sided colorectal resection with rectal anastomosis. Dis Colon Rectum 2003; 46:653-660.
13. Walz JM, Paterson CA, Seligowski JM, et al: Surgical site infection following bowel surgery: retrospective analysis of 1,446 patients. Arch Surg 2006; 141:1014-1018.
14. Bernard AC, Davenport DL, Chang PK, et al: Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208: 931-937.
15. Madbouly KM, Senagore AJ, Remzi FH, et al: Perioperative blood transfusions increase infectious complications after ileo-anal pouch procedures (IPAA). Int J Colorec-tal Dis 2006; 21:807-813.
16. Konishi T, Watanabe T, Kishimoto J, et al: Risk factors for anastomotic leakage after surgery for colorectal cancer: results of prospective surveillance. J Am Coll Surg 2006; 202: 439-444.
17. Markel TA, Lou DC, Pfefferkorn M, et al: Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis. Surger y 2008; 14 4 : 540-547.
18. Lake JP, Firoozmand E, Kang JC, et al: Effect of high-dose steroids on anastomotic complications after proctocolectomy with ileal pouch-anal anastomosis. J Gastrointest Surg 2004; 8:547-551.
19. Heuschen UA, Hinz U, Allemeyer EH, et al: Risk factors for ileoanal J pouch-related septic complications in ulcerative colitis and familial adenomatous polyposis. Ann Surg 2002; 235: 207-216.
20. Lim M, Sagar P, Abdulgader A, et al: The impact of preoperative immunomodulation on pouch-related septic complications after ile-al pouch-anal anastomosis. Dis Colon Rectum 2007; 50:943-951.
21. Hahnloser D, Pemberton JH, Wolff BG, et al: Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg 2007; 94: 333-340.
22. Mahadevan U, Loftus EV, Tremaine WJ, et al: Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. inflamm Bowel Dis 2002; 8: 311-316.
23. Hyde GM, Jewell DP, Kettlewell MG, et al: Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications. Dis Colon Rectum 2001; 44: 1436-1440.
24. Schluender SJ, Ippoliti A, Dubinsky M, et al: Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis. Dis Colon Rectum 2007; 50:1747-1753.
25. Colombel JF, Loftus EV Jr, Tremaine WJ, et al: The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients. Gastroenterology 2004; 126: 19-31.
26. Appau KA, Fazio VW, Shen B, et al: Use of infliximab within 3 months of ileocolonic resections in associated with adverse postoperative outcomes in Crohn's patients. J Gas-trointest Surg 2008; 12:1738-1744.
27. Rutgeerts P, Sandborn WJ, Feagan BG, et al: Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005; 353: 2462-2476. Erratum in: N Engl J Med 20 06; 354: 2200.
28. Selvasekar CR, Cima RR, Larson DW, et al: Ef fect of inflix imab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007; 204:956-963.
29. Mor IJ, Vogel JD, Moreira Ada L, et al: In-fliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 2008; 51: 1202-1210.
30. Kunitake H, Hodin R, Shellito PC, et al: Peri-operative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointestinal Surg 2008; 12:1730-1737.
31. Ferrante M, D'Hoore A, Vermeire S, et al: Corticosteroids but not infliximab increase short-term postoperative infectious complication in patients with ulcerative colitis. In-flamm Bowel Dis 2009; 15:1062-1070.
32. Swoger JM, Loftus EV Jr: Pre-operative in-fliximab exposure and the occurrence of post-operative complications following proctocolectomy and ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC). Gastroenterology 2009;136:A188.
33. Lopes J V, Menonca de Freitas LA, Marques RD, et al: Analysis of the tensile strength on the healing of the abdominal wall of rats treated with infliximab. Acta Cir Bras 2008; 23: 441-446.
34. Pemberton JH, Kelly KA, Beart RW, et al: Ileal pouch-anal anastomosis for chronic ul-cerative colitis: long-term results. Ann Surg 1987; 206:504-513.
35. Tan HT, Connolly AB, Morton D, et al: Results of restorative proctocolectomy in the elderly. Int J Colorectal Dis 1997; 12:319-322 .
36. Olsen Ko, Joelsson M, Laurberg S, et al: Fertility after ileal pouch-anal anastomosis in women with ulcertive colitis. Br J Surg 1999; 86:493-495.
37. Lepisto A, Sarna S, Tiitinen A, et al: Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg 2007; 94: 478-482.
38. Olsen KO, Juul S, Bulow S, et al: Female fecundity before and after operations for familial adenomatous polyposis. Br J Surg 2003; 90:227-231.